• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

Research Brief on 2,6-Diamino-1-methyl-4(1H)-pyrimidinone (CAS: 51093-34-6): Recent Advances and Applications

2,6-Diamino-1-methyl-4(1H)-pyrimidinone (CAS: 51093-34-6) is a pyrimidine derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. Recent studies have explored its potential as a key intermediate in the synthesis of nucleoside analogs, antiviral agents, and enzyme inhibitors. This research brief aims to summarize the latest findings related to this compound, focusing on its chemical properties, biological activities, and therapeutic potential.

One of the most notable advancements in the study of 2,6-Diamino-1-methyl-4(1H)-pyrimidinone is its role in the synthesis of novel antiviral compounds. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound serves as a critical building block for the development of inhibitors targeting viral polymerases. The researchers utilized a structure-activity relationship (SAR) approach to optimize the compound's efficacy, resulting in derivatives with enhanced binding affinity and reduced cytotoxicity. These findings highlight the potential of 51093-34-6 as a scaffold for antiviral drug design.

In addition to its antiviral applications, recent research has investigated the compound's utility in cancer therapy. A study in Bioorganic & Medicinal Chemistry Letters (2024) reported that 2,6-Diamino-1-methyl-4(1H)-pyrimidinone derivatives exhibit potent inhibitory effects on certain kinases involved in tumor proliferation. The study employed molecular docking and in vitro assays to validate the compound's interaction with kinase targets, suggesting its promise as a lead compound for oncology drug development. Further preclinical studies are underway to evaluate its pharmacokinetics and toxicity profiles.

The chemical stability and synthetic accessibility of 51093-34-6 have also been subjects of recent investigation. A 2024 paper in Organic Process Research & Development detailed an optimized synthetic route for large-scale production of the compound, addressing challenges such as yield and purity. The authors emphasized the importance of green chemistry principles in the process, reducing the environmental impact while maintaining high efficiency. This advancement is expected to facilitate broader industrial adoption of the compound for pharmaceutical applications.

Looking ahead, researchers are exploring the potential of 2,6-Diamino-1-methyl-4(1H)-pyrimidinone in emerging areas such as targeted drug delivery and personalized medicine. Its ability to function as a versatile pharmacophore makes it an attractive candidate for conjugation with nanoparticles and other delivery systems. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these discoveries into clinical applications.

In conclusion, the recent research on 2,6-Diamino-1-methyl-4(1H)-pyrimidinone (CAS: 51093-34-6) underscores its multifaceted role in drug discovery and development. From antiviral and anticancer applications to advancements in synthetic chemistry, this compound continues to demonstrate significant potential. Future studies will likely focus on optimizing its therapeutic efficacy and expanding its applications in precision medicine. This brief serves as a timely update for researchers and industry professionals seeking to leverage the latest developments in this field.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)